{
  "DOI": "10.1007/s10689-010-9362-5",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-010-9362-5",
  "alternative-id": [
    "9362"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Vargas",
      "given": "Ana Cristina",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Silva",
      "given": "Leonard Da",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lakhani",
      "given": "Sunil R.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2010,
        6,
        24
      ]
    ],
    "date-time": "2010-06-24T09:44:59Z",
    "timestamp": 1277372699000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:03Z",
    "timestamp": 1559252763000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        24
      ]
    ],
    "date-time": "2023-12-24T23:49:29Z",
    "timestamp": 1703461769484
  },
  "is-referenced-by-count": 16,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2010,
        6,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2010,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2010,
            6,
            25
          ]
        ],
        "date-time": "2010-06-25T00:00:00Z",
        "timestamp": 1277424000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-010-9362-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-010-9362-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-010-9362-5",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "545-553",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2010,
        6,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        6,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1093/jnci/94.18.1358",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "1358",
      "issue": "18",
      "journal-title": "J Natl Cancer Inst",
      "key": "9362_CR1",
      "unstructured": "Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358–1365",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMra012284",
      "author": "R Wooster",
      "doi-asserted-by": "crossref",
      "first-page": "2339",
      "issue": "23",
      "journal-title": "N Engl J Med",
      "key": "9362_CR2",
      "unstructured": "Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348(23):2339–2347",
      "volume": "348",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0092-8674(02)00615-3",
      "author": "AR Venkitaraman",
      "doi-asserted-by": "crossref",
      "first-page": "171",
      "issue": "2",
      "journal-title": "Cell",
      "key": "9362_CR3",
      "unstructured": "Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171–182",
      "volume": "108",
      "year": "2002"
    },
    {
      "DOI": "10.1111/j.1365-2559.2006.02538.x",
      "author": "RL Balleine",
      "doi-asserted-by": "crossref",
      "first-page": "523",
      "issue": "5",
      "journal-title": "Histopathology",
      "key": "9362_CR4",
      "unstructured": "Balleine RL, Murali R, Bilous AM et al (2006) Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology 49(5):523–532",
      "volume": "49",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1399-0004.2008.01111.x",
      "author": "C Cybulski",
      "doi-asserted-by": "crossref",
      "first-page": "72",
      "issue": "1",
      "journal-title": "Clin Genet",
      "key": "9362_CR5",
      "unstructured": "Cybulski C, Huzarski T, Byrski T et al (2009) Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention. Clin Genet 75(1):72–78",
      "volume": "75",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2003.07.007",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "593",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR6",
      "unstructured": "Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL (2003) Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21(4):593–601",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1001/jama.297.23.2587",
      "author": "JN Weitzel",
      "doi-asserted-by": "crossref",
      "first-page": "2587",
      "issue": "23",
      "journal-title": "JAMA",
      "key": "9362_CR7",
      "unstructured": "Weitzel JN, Lagos VI, Cullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297(23):2587–2595",
      "volume": "297",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2008.17.5869",
      "author": "D Huo",
      "doi-asserted-by": "crossref",
      "first-page": "1184",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR8",
      "unstructured": "Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, hispanic, and other minority families in the United States. J Clin Oncol 27(8):1184–1190",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmg.2008.061903",
      "author": "PA James",
      "doi-asserted-by": "crossref",
      "first-page": "765",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "9362_CR9",
      "unstructured": "James PA, Harris M, Lindeman GJ, Mitchell G (2008) Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers. J Med Genet 45(11):765–766",
      "volume": "45",
      "year": "2008"
    },
    {
      "DOI": "10.7326/0003-4819-147-7-200710020-00002",
      "author": "G Parmigiani",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "issue": "7",
      "journal-title": "Ann Intern Med",
      "key": "9362_CR10",
      "unstructured": "Parmigiani G, Chen S, Iversen ES Jr et al (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147(7):441–450",
      "volume": "147",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-1090",
      "author": "AW Kurian",
      "doi-asserted-by": "crossref",
      "first-page": "1084",
      "issue": "4",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9362_CR11",
      "unstructured": "Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California breast cancer family registry. Cancer Epidemiol Biomarkers Prev 18(4):1084–1091",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cncr.10223",
      "author": "KM Shannon",
      "doi-asserted-by": "crossref",
      "first-page": "305",
      "issue": "2",
      "journal-title": "Cancer",
      "key": "9362_CR12",
      "unstructured": "Shannon KM, Lubratovich ML, Finkelstein DM, Smith BL, Powell SN, Seiden MV (2002) Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer 94(2):305–313",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2002.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "1480",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR13",
      "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480–1490",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "9362_CR14",
      "unstructured": "Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "key": "9362_CR15",
      "unstructured": "Struewing JP, Watson P, Easton DF, Ponder BA, Lynch HT, Tucker MA (1995) Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monogr (17): 33–35"
    },
    {
      "DOI": "10.1093/jnci/91.17.1475",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1475",
      "issue": "17",
      "journal-title": "J Natl Cancer Inst",
      "key": "9362_CR16",
      "unstructured": "Rebbeck TR, Levin AM, Eisen A et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475–1479",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1093/jnci/93.21.1633",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "1633",
      "issue": "21",
      "journal-title": "J Natl Cancer Inst",
      "key": "9362_CR17",
      "unstructured": "Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJM200107193450301",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "issue": "3",
      "journal-title": "N Engl J Med",
      "key": "9362_CR18",
      "unstructured": "Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJMoa020119",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "1609",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "9362_CR19",
      "unstructured": "Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609–1615",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1055",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR20",
      "unstructured": "Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22(6):1055–1062",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1056/NEJM199705153362002",
      "author": "FJ Couch",
      "doi-asserted-by": "crossref",
      "first-page": "1409",
      "issue": "20",
      "journal-title": "N Engl J Med",
      "key": "9362_CR21",
      "unstructured": "Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336(20):1409–1415",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1086/301670",
      "author": "G Parmigiani",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "9362_CR22",
      "unstructured": "Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145–158",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.2002.05.121",
      "author": "DA Berry",
      "doi-asserted-by": "crossref",
      "first-page": "2701",
      "issue": "11",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR23",
      "unstructured": "Berry DA, Iversen ES Jr, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701–2712",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.2003.017996",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "474",
      "issue": "6",
      "journal-title": "J Med Genet",
      "key": "9362_CR24",
      "unstructured": "Evans DG, Eccles DM, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41(6):474–480",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.bjc.6604305",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1457",
      "issue": "8",
      "journal-title": "Br J Cancer",
      "key": "9362_CR25",
      "unstructured": "Antoniou AC, Cunningham AP, Peto J et al (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98(8):1457–1466",
      "volume": "98",
      "year": "2008"
    },
    {
      "DOI": "10.1002/sim.1668",
      "author": "J Tyrer",
      "doi-asserted-by": "crossref",
      "first-page": "1111",
      "issue": "7",
      "journal-title": "Stat Med",
      "key": "9362_CR26",
      "unstructured": "Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111–1130",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/89.3.227",
      "author": "DA Berry",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "issue": "3",
      "journal-title": "J Natl Cancer Inst",
      "key": "9362_CR27",
      "unstructured": "Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89(3):227–238",
      "volume": "89",
      "year": "1997"
    },
    {
      "author": "KA Calzone",
      "first-page": "228",
      "issue": "4",
      "journal-title": "Cancer Pract",
      "key": "9362_CR28",
      "unstructured": "Calzone KA, Stopfer J, Blackwood A, Weber BL (1997) Establishing a cancer risk evaluation program. Cancer Pract 5(4):228–233",
      "volume": "5",
      "year": "1997"
    },
    {
      "DOI": "10.1200/JCO.1998.16.7.2417",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "2417",
      "issue": "7",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR29",
      "unstructured": "Frank TS, Manley SA, Olopade OI et al (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16(7):2417–2425",
      "volume": "16",
      "year": "1998"
    },
    {
      "DOI": "10.1093/aje/152.12.1154",
      "author": "H Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "1154",
      "issue": "12",
      "journal-title": "Am J Epidemiol",
      "key": "9362_CR30",
      "unstructured": "Anderson H, Bladstrom A, Olsson H, Moller TR (2000) Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol 152(12):1154–1163",
      "volume": "152",
      "year": "2000"
    },
    {
      "DOI": "10.1038/sj.bjc.6602175",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1580",
      "issue": "8",
      "journal-title": "Br J Cancer",
      "key": "9362_CR31",
      "unstructured": "Antoniou AC, Pharoah PP, Smith P, Easton DF (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91(8):1580–1590",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.2005.031989",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "e39",
      "issue": "7",
      "journal-title": "J Med Genet",
      "key": "9362_CR32",
      "unstructured": "Evans DG, Lalloo F, Wallace A, Rahman N (2005) Update on the manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 42(7):e39",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1136/jmg.2009.067850",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "811",
      "issue": "12",
      "journal-title": "J Med Genet",
      "key": "9362_CR33",
      "unstructured": "Evans DG, Lalloo F, Cramer A et al (2009) Addition of pathology and biomarker information significantly improves the performance of the manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 46(12):811–817",
      "volume": "46",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmg.2007.056556",
      "author": "AC Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "425",
      "issue": "7",
      "journal-title": "J Med Genet",
      "key": "9362_CR34",
      "unstructured": "Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, myriad and the manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425–431",
      "volume": "45",
      "year": "2008"
    },
    {
      "author": "SR Lakhani",
      "first-page": "782",
      "issue": "3",
      "journal-title": "Clin Cancer Res",
      "key": "9362_CR35",
      "unstructured": "Lakhani SR, Gusterson BA, Jacquemier J et al (2000) The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6(3):782–789",
      "volume": "6",
      "year": "2000"
    },
    {
      "DOI": "10.1093/jnci/90.15.1138",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "1138",
      "issue": "15",
      "journal-title": "J Natl Cancer Inst",
      "key": "9362_CR36",
      "unstructured": "Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90(15):1138–1145",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-2230",
      "author": "RA Oldenburg",
      "doi-asserted-by": "crossref",
      "first-page": "1693",
      "issue": "6",
      "journal-title": "Clin Cancer Res",
      "key": "9362_CR37",
      "unstructured": "Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H et al (2006) Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. Clin Cancer Res 12(6):1693–1700",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1023/B:BREA.0000003836.91844.b5",
      "author": "E Sensi",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9362_CR38",
      "unstructured": "Sensi E, Tancredi M, Aretini P et al (2003) p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations. Breast Cancer Res Treat 82(1):1–9",
      "volume": "82",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2002.09.023",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "2310",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR39",
      "unstructured": "Lakhani SR, Van De Vijver MJ, Jacquemier J et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318",
      "volume": "20",
      "year": "2002"
    },
    {
      "author": "J Palacios",
      "first-page": "3606",
      "issue": "10 Pt 1",
      "journal-title": "Clin Cancer Res",
      "key": "9362_CR40",
      "unstructured": "Palacios J, Honrado E, Osorio A et al (2003) Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 9(10 Pt 1):3606–3614",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.1038/modpathol.3800969",
      "author": "E Honrado",
      "doi-asserted-by": "crossref",
      "first-page": "1298",
      "issue": "12",
      "journal-title": "Mod Pathol",
      "key": "9362_CR41",
      "unstructured": "Honrado E, Osorio A, Milne RL et al (2007) Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod Pathol 20(12):1298–1306",
      "volume": "20",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2424",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "5175",
      "issue": "14",
      "journal-title": "Clin Cancer Res",
      "key": "9362_CR42",
      "unstructured": "Lakhani SR, Reis-Filho JS, Fulford L et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11(14):5175–5180",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-03-2970",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "830",
      "issue": "3",
      "journal-title": "Cancer Res",
      "key": "9362_CR43",
      "unstructured": "Foulkes WD, Brunet JS, Stefansson IM et al (2004) The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res 64(3):830–835",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1080/00313020220147113",
      "author": "JE Armes",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "issue": "4",
      "journal-title": "Pathology",
      "key": "9362_CR44",
      "unstructured": "Armes JE, Venter DJ (2002) The pathology of inherited breast cancer. Pathology 34(4):309–314",
      "volume": "34",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10549-006-9184-1",
      "author": "SM Pinilla",
      "doi-asserted-by": "crossref",
      "first-page": "85",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9362_CR45",
      "unstructured": "Pinilla SM, Honrado E, Hardisson D, Benitez J, Palacios J (2006) Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat 99(1):85–90",
      "volume": "99",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-2132",
      "author": "EA Rakha",
      "doi-asserted-by": "crossref",
      "first-page": "2302",
      "issue": "7",
      "journal-title": "Clin Cancer Res",
      "key": "9362_CR46",
      "unstructured": "Rakha EA, Elsheikh SE, Aleskandarany MA et al (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15(7):2302–2310",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.bjc.6602557",
      "author": "F Weber",
      "doi-asserted-by": "crossref",
      "first-page": "1922",
      "issue": "10",
      "journal-title": "Br J Cancer",
      "key": "9362_CR47",
      "unstructured": "Weber F, Fukino K, Sawada T et al (2005) Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. Br J Cancer 92(10):1922–1926",
      "volume": "92",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.onc.1209875",
      "author": "E Honrado",
      "doi-asserted-by": "crossref",
      "first-page": "5837",
      "issue": "43",
      "journal-title": "Oncogene",
      "key": "9362_CR48",
      "unstructured": "Honrado E, Osorio A, Palacios J, Benitez J (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25(43):5837–5845",
      "volume": "25",
      "year": "2006"
    },
    {
      "author": "R Lidereau",
      "first-page": "1206",
      "issue": "5",
      "journal-title": "Cancer Res",
      "key": "9362_CR49",
      "unstructured": "Lidereau R, Eisinger F, Champeme MH et al (2000) Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res 60(5):1206–1210",
      "volume": "60",
      "year": "2000"
    },
    {
      "author": "J Chang",
      "first-page": "1739",
      "issue": "6",
      "journal-title": "Clin Cancer Res",
      "key": "9362_CR50",
      "unstructured": "Chang J, Hilsenbeck SG, Sng JH, Wong J, Ragu GC (2001) Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients. Clin Cancer Res 7(6):1739–1742",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1002/(SICI)1098-2264(200002)27:2\u003c130::AID-GCC3\u003e3.0.CO;2-U",
      "author": "L Cortesi",
      "doi-asserted-by": "crossref",
      "first-page": "130",
      "issue": "2",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "9362_CR51",
      "unstructured": "Cortesi L, Turchetti D, Bertoni C et al (2000) Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations. Genes Chromosomes Cancer 27(2):130–135",
      "volume": "27",
      "year": "2000"
    },
    {
      "DOI": "10.1097/01.pas.0000213273.22844.1a",
      "author": "G Farshid",
      "doi-asserted-by": "crossref",
      "first-page": "1357",
      "issue": "11",
      "journal-title": "Am J Surg Pathol",
      "key": "9362_CR52",
      "unstructured": "Farshid G, Balleine RL, Cummings M, Waring P (2006) Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol 30(11):1357–1366",
      "volume": "30",
      "year": "2006"
    },
    {
      "DOI": "10.1002/(SICI)1097-0215(19990621)84:3\u003c263::AID-IJC11\u003e3.0.CO;2-G",
      "author": "F Eisinger",
      "doi-asserted-by": "crossref",
      "first-page": "263",
      "issue": "3",
      "journal-title": "Int J Cancer",
      "key": "9362_CR53",
      "unstructured": "Eisinger F, Nogues C, Guinebretiere JM et al (1999) Novel indications for BRCA1 screening using individual clinical and morphological features. Int J Cancer 84(3):263–267",
      "volume": "84",
      "year": "1999"
    },
    {
      "DOI": "10.1186/1471-2407-9-86",
      "author": "SR Young",
      "doi-asserted-by": "crossref",
      "first-page": "86",
      "journal-title": "BMC Cancer",
      "key": "9362_CR54",
      "unstructured": "Young SR, Pilarski RT, Donenberg T et al (2009) The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer 9:86",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2064",
      "author": "JB Arnes",
      "doi-asserted-by": "crossref",
      "first-page": "4003",
      "issue": "11",
      "journal-title": "Clin Cancer Res",
      "key": "9362_CR55",
      "unstructured": "Arnes JB, Brunet JS, Stefansson I et al (2005) Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res 11(11):4003–4011",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1097/PAS.0b013e31819c1c93",
      "author": "LC Collins",
      "doi-asserted-by": "crossref",
      "first-page": "1093",
      "issue": "7",
      "journal-title": "Am J Surg Pathol",
      "key": "9362_CR56",
      "unstructured": "Collins LC, Martyniak A, Kandel MJ et al (2009) Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol 33(7):1093–1097",
      "volume": "33",
      "year": "2009"
    },
    {
      "DOI": "10.1093/jnci/91.5.469",
      "author": "KA Phillips",
      "doi-asserted-by": "crossref",
      "first-page": "469",
      "issue": "5",
      "journal-title": "J Natl Cancer Inst",
      "key": "9362_CR57",
      "unstructured": "Phillips KA, Nichol K, Ozcelik H et al (1999) Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. J Natl Cancer Inst 91(5):469–473",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.onc.1202106",
      "author": "T Crook",
      "doi-asserted-by": "crossref",
      "first-page": "1681",
      "issue": "13",
      "journal-title": "Oncogene",
      "key": "9362_CR58",
      "unstructured": "Crook T, Brooks LA, Crossland S et al (1998) p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene 17(13):1681–1689",
      "volume": "17",
      "year": "1998"
    },
    {
      "author": "JE Armes",
      "first-page": "2011",
      "issue": "8",
      "journal-title": "Cancer Res",
      "key": "9362_CR59",
      "unstructured": "Armes JE, Trute L, White D et al (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 59(8):2011–2017",
      "volume": "59",
      "year": "1999"
    },
    {
      "DOI": "10.1097/00019606-199609000-00007",
      "author": "DW Visscher",
      "doi-asserted-by": "crossref",
      "first-page": "187",
      "issue": "3",
      "journal-title": "Diagn Mol Pathol",
      "key": "9362_CR60",
      "unstructured": "Visscher DW, Sarkar FH, Shimoyama RK, Crissman JD (1996) Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma. Diagn Mol Pathol 5(3):187–193",
      "volume": "5",
      "year": "1996"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-08-3426",
      "author": "H Holstege",
      "doi-asserted-by": "crossref",
      "first-page": "3625",
      "issue": "8",
      "journal-title": "Cancer Res",
      "key": "9362_CR61",
      "unstructured": "Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J (2009) High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res 69(8):3625–3633",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-08-1560",
      "author": "E Manie",
      "doi-asserted-by": "crossref",
      "first-page": "663",
      "issue": "2",
      "journal-title": "Cancer Res",
      "key": "9362_CR62",
      "unstructured": "Manie E, Vincent-Salomon A, Lehmann-Che J et al (2009) High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Cancer Res 69(2):663–671",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.1038/90108",
      "author": "X Xu",
      "doi-asserted-by": "crossref",
      "first-page": "266",
      "issue": "3",
      "journal-title": "Nat Genet",
      "key": "9362_CR63",
      "unstructured": "Xu X, Qiao W, Linke SP et al (2001) Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 28(3):266–271",
      "volume": "28",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.onc.1206439",
      "author": "PP Ongusaha",
      "doi-asserted-by": "crossref",
      "first-page": "3749",
      "issue": "24",
      "journal-title": "Oncogene",
      "key": "9362_CR64",
      "unstructured": "Ongusaha PP, Ouchi T, Kim KT et al (2003) BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest. Oncogene 22(24):3749–3758",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-03-2270",
      "author": "AM Cheung",
      "doi-asserted-by": "crossref",
      "first-page": "1959",
      "issue": "6",
      "journal-title": "Cancer Res",
      "key": "9362_CR65",
      "unstructured": "Cheung AM, Elia A, Tsao MS et al (2004) Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/−) mutant mice. Cancer Res 64(6):1959–1965",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10549-004-1536-0",
      "author": "J Palacios",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9362_CR66",
      "unstructured": "Palacios J, Honrado E, Osorio A et al (2005) Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat 90(1):5–14",
      "volume": "90",
      "year": "2005"
    },
    {
      "DOI": "10.1136/jcp.2005.032151",
      "author": "P Groep van der",
      "doi-asserted-by": "crossref",
      "first-page": "611",
      "issue": "6",
      "journal-title": "J Clin Pathol",
      "key": "9362_CR67",
      "unstructured": "van der Groep P, Bouter A, van der Zanden R et al (2006) Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 59(6):611–617",
      "volume": "59",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.cancergencyto.2008.11.003",
      "author": "D Gadzicki",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "issue": "2",
      "journal-title": "Cancer Genet Cytogenet",
      "key": "9362_CR68",
      "unstructured": "Gadzicki D, Schubert A, Fischer C et al (2009) Histopathological criteria and selection algorithms for BRCA1 genetic testing. Cancer Genet Cytogenet 189(2):105–111",
      "volume": "189",
      "year": "2009"
    },
    {
      "DOI": "10.1054/bjoc.2000.1438",
      "author": "P Freneaux",
      "doi-asserted-by": "crossref",
      "first-page": "1318",
      "issue": "10",
      "journal-title": "Br J Cancer",
      "key": "9362_CR69",
      "unstructured": "Freneaux P, Stoppa-Lyonnet D, Mouret E et al (2000) Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer 83(10):1318–1322",
      "volume": "83",
      "year": "2000"
    },
    {
      "DOI": "10.1136/mp.54.4.259",
      "author": "SA Vaziri",
      "doi-asserted-by": "crossref",
      "first-page": "259",
      "issue": "4",
      "journal-title": "Mol Pathol",
      "key": "9362_CR70",
      "unstructured": "Vaziri SA, Tubbs RR, Darlington G, Casey G (2001) Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers. Mol Pathol 54(4):259–263",
      "volume": "54",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.humpath.2007.10.011",
      "author": "EA Rakha",
      "doi-asserted-by": "crossref",
      "first-page": "857",
      "issue": "6",
      "journal-title": "Hum Pathol",
      "key": "9362_CR71",
      "unstructured": "Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO (2008) Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol 39(6):857–865",
      "volume": "39",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.98.1.130",
      "author": "C Beger",
      "doi-asserted-by": "crossref",
      "first-page": "130",
      "issue": "1",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "9362_CR72",
      "unstructured": "Beger C, Pierce LN, Kruger M et al (2001) Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A 98(1):130–135",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.onc.1210014",
      "author": "NC Turner",
      "doi-asserted-by": "crossref",
      "first-page": "2126",
      "issue": "14",
      "journal-title": "Oncogene",
      "key": "9362_CR73",
      "unstructured": "Turner NC, Reis-Filho JS, Russell AM et al (2007) BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26(14):2126–2132",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1940-6207.CAPR-08-0050",
      "author": "B Arun",
      "doi-asserted-by": "crossref",
      "first-page": "122",
      "issue": "2",
      "journal-title": "Cancer Prev Res (Phila Pa)",
      "key": "9362_CR74",
      "unstructured": "Arun B, Vogel KJ, Lopez A et al (2009) High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers. Cancer Prev Res (Phila Pa) 2(2):122–127",
      "volume": "2",
      "year": "2009"
    },
    {
      "DOI": "10.1097/01.pas.0000213351.49767.0f",
      "author": "AL Bane",
      "doi-asserted-by": "crossref",
      "first-page": "121",
      "issue": "1",
      "journal-title": "Am J Surg Pathol",
      "key": "9362_CR75",
      "unstructured": "Bane AL, Beck JC, Bleiweiss I et al (2007) BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol 31(1):121–128",
      "volume": "31",
      "year": "2007"
    },
    {
      "DOI": "10.1002/path.2358",
      "author": "PT Simpson",
      "doi-asserted-by": "crossref",
      "first-page": "231",
      "issue": "3",
      "journal-title": "J Pathol",
      "key": "9362_CR76",
      "unstructured": "Simpson PT, Reis-Filho JS, Lambros MB et al (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215(3):231–244",
      "volume": "215",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2005.01.9737",
      "author": "PA James",
      "doi-asserted-by": "crossref",
      "first-page": "707",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR77",
      "unstructured": "James PA, Doherty R, Harris M et al (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24(4):707–715",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1186/bcr2576",
      "author": "N Mavaddat",
      "doi-asserted-by": "crossref",
      "first-page": "R28",
      "journal-title": "Breast Cancer Res",
      "key": "9362_CR78",
      "unstructured": "Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antonis AC (2010) Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12: R28",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1186/bcr2223",
      "author": "EB Gomez Garcia",
      "doi-asserted-by": "crossref",
      "first-page": "R8",
      "issue": "1",
      "journal-title": "Breast Cancer Res",
      "key": "9362_CR79",
      "unstructured": "Gomez Garcia EB, Oosterwijk JC, Timmermans M et al (2009) A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history. Breast Cancer Res 11(1):R8",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.1997.03540350065035",
      "author": "W Burke",
      "doi-asserted-by": "crossref",
      "first-page": "915",
      "issue": "11",
      "journal-title": "JAMA",
      "key": "9362_CR80",
      "unstructured": "Burke W, Petersen G, Lynch P et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer genetics studies consortium. JAMA 277(11):915–919",
      "volume": "277",
      "year": "1997"
    },
    {
      "DOI": "10.1093/annonc/mdn724",
      "author": "M Pensabene",
      "doi-asserted-by": "crossref",
      "first-page": "874",
      "issue": "5",
      "journal-title": "Ann Oncol",
      "key": "9362_CR81",
      "unstructured": "Pensabene M, Spagnoletti I, Capuano I et al (2009) Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol 20(5):874–878",
      "volume": "20",
      "year": "2009"
    },
    {
      "DOI": "10.1086/424388",
      "author": "DE Goldgar",
      "doi-asserted-by": "crossref",
      "first-page": "535",
      "issue": "4",
      "journal-title": "Am J Hum Genet",
      "key": "9362_CR82",
      "unstructured": "Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75(4):535–544",
      "volume": "75",
      "year": "2004"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-3546",
      "author": "G Chenevix-Trench",
      "doi-asserted-by": "crossref",
      "first-page": "2019",
      "issue": "4",
      "journal-title": "Cancer Res",
      "key": "9362_CR83",
      "unstructured": "Chenevix-Trench G, Healey S, Lakhani S et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66(4):2019–2027",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1002/humu.20470",
      "author": "A Osorio",
      "doi-asserted-by": "crossref",
      "first-page": "477",
      "issue": "5",
      "journal-title": "Hum Mutat",
      "key": "9362_CR84",
      "unstructured": "Osorio A, Milne RL, Honrado E et al (2007) Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information. Hum Mutat 28(5):477–485",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.mrfmmm.2008.07.005",
      "author": "S Tommasi",
      "doi-asserted-by": "crossref",
      "first-page": "64",
      "issue": "1–2",
      "journal-title": "Mutat Res",
      "key": "9362_CR85",
      "unstructured": "Tommasi S, Pilato B, Pinto R et al (2008) Molecular and in silico analysis of BRCA1 and BRCA2 variants. Mutat Res 644(1–2):64–70",
      "volume": "644",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2008.17.8228",
      "author": "AD Spearman",
      "doi-asserted-by": "crossref",
      "first-page": "5393",
      "issue": "33",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR86",
      "unstructured": "Spearman AD, Sweet K, Zhou XP, McLennan J, Couch FJ, Toland AE (2008) Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance. J Clin Oncol 26(33):5393–5400",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1136/jmg.2005.033258",
      "author": "PK Lovelock",
      "doi-asserted-by": "crossref",
      "first-page": "74",
      "issue": "1",
      "journal-title": "J Med Genet",
      "key": "9362_CR87",
      "unstructured": "Lovelock PK, Healey S, Au W et al (2006) Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet 43(1):74–83",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0140-6736(96)10109-4",
      "author": "BCL Consortium",
      "doi-asserted-by": "crossref",
      "first-page": "1505",
      "issue": "9064",
      "journal-title": "Lancet",
      "key": "9362_CR88",
      "unstructured": "Consortium BCL (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349(9064):1505–1510",
      "volume": "349",
      "year": "1997"
    },
    {
      "DOI": "10.1002/cncr.11048",
      "author": "C Adem",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Cancer",
      "key": "9362_CR89",
      "unstructured": "Adem C, Reynolds C, Soderberg CL et al (2003) Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97(1):1–11",
      "volume": "97",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2005.04.0345",
      "author": "ES Hwang",
      "doi-asserted-by": "crossref",
      "first-page": "642",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "9362_CR90",
      "unstructured": "Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL (2007) Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol 25(6):642–647",
      "volume": "25",
      "year": "2007"
    }
  ],
  "reference-count": 90,
  "references-count": 90,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-010-9362-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers"
  ],
  "type": "journal-article",
  "volume": "9"
}